Growth Metrics

Jazz Pharmaceuticals (JAZZ) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Jazz Pharmaceuticals 14.64 Bn 12.79 Bn 934.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.95%
Dec 31, 2025 9.08%
Sep 30, 2025 6.82%
Jun 30, 2025 -11.22%
Mar 31, 2025 1.98%
Dec 31, 2024 -1.85%
Sep 30, 2024 10.86%
Jun 30, 2024 1.79%
Mar 31, 2024 -1.08%
Dec 31, 2023 7.10%
Sep 30, 2023 -1.03%
Jun 30, 2023 5.72%
Mar 31, 2023 8.08%
Dec 31, 2022 12.40%
Sep 30, 2022 -14.23%
Jun 30, 2022 -11.30%
Mar 31, 2022 -9.00%
Dec 31, 2021 0.68%
Sep 30, 2021 -4.67%
Jun 30, 2021 8.79%
Mar 31, 2021 3.77%
Dec 31, 2020 8.37%
Sep 30, 2020 7.49%
Jun 30, 2020 11.87%
Mar 31, 2020 -9.72%
Dec 31, 2019 1.85%
Sep 30, 2019 2.38%
Jun 30, 2019 9.27%
Mar 31, 2019 -0.98%
Dec 31, 2018 -8.92%
Sep 30, 2018 5.49%
Jun 30, 2018 2.99%
Mar 31, 2018 2.71%
Dec 31, 2017 9.87%
Sep 30, 2017 12.19%
Jun 30, 2017 10.94%
Mar 31, 2017 5.68%
Dec 31, 2016 2.51%
Sep 30, 2016 1.65%
Jun 30, 2016 5.42%
Mar 31, 2016 0.15%
Dec 31, 2015 9.14%
Sep 30, 2015 8.06%
Jun 30, 2015 10.84%
Mar 31, 2015 -4.80%
Dec 31, 2014 2.28%
Sep 30, 2014 4.73%
Jun 30, 2014 1.07%
Mar 31, 2014 -2.24%
Dec 31, 2013 4.17%
Sep 30, 2013 5.81%
Jun 30, 2013 1.17%
Mar 31, 2013 3.62%
Dec 31, 2012 26.54%
Sep 30, 2012 6.57%
Jun 30, 2012 6.35%
Mar 31, 2012 305.54%
Dec 31, 2011 36.41%
Sep 30, 2011 39.11%